OMITTED

What the news leaves out.

← Omitted front page

Palmer Luckey Launches Genetically Engineered War Dog Startup

5 sources · updated 2026-10-25
Left 40% Center 40% Right 20%
2 left · 2 center · 1 right

What happened

Palmer Luckey, cofounder of defense firm Anduril, and Ben Lamm, cofounder of biotechnology company Colossal Biosciences, announced Warhound, a Texas startup that raised $200 million in seed funding to clone and genetically engineer working dogs for the U.S. military, law enforcement, and first responders. Led by CEO David Spirk, a former Marine Corps veteran and Palantir counselor, the company says it will rebuild a domestic supply after most of the roughly 1,600 U.S. military working dogs have been sourced from Europe and fewer than half of dogs that enter military training complete it. Warhound plans to clone elite Belgian Malinois, German Shepherds, and Labrador retrievers, edit genes to reduce ailments such as hip dysplasia and potentially enhance traits like scent detection, and fit the animals with Anduril external hardware including protective armor and sensors; Colossal owns a stake, while Luckey and Anduril hold no equity. Backers include Sequoia Capital, ARK Invest, In-Q-Tel, Franklin Templeton, and 8VC. The company, which says it is working with the American Humane Society, hopes its first genetically engineered puppies will be born in early 2027.
Sourcing check · Mostly on the record · 5 articles

4 of 5 articles cite a named source for the story. It was on the record from the first report.

What these terms mean and how they're counted
On the record · names a source 4 of 5
On the record means the article cites a source by name for the story's main claim: a person, or an institution speaking officially, such as a company statement or a named agency's spokesperson. The opposite is an unnamed source. The count is how many of the counted articles cite at least one such source; the names are everyone named across them, each once however the articles spell it. Here: Warhound, Shaun Maguire and Ben Lamm
Primary evidence · cites a document or data 3 of 5
Primary evidence means the article cites a record you could check yourself: a court filing or ruling, a dataset or report, a recording or transcript, an official statement or press release, market data. A quote is not a document. The count is how many articles cite one. Here: press release, news interview, company statement
Credits another outlet 0 of 5
The article says the story comes from another outlet's reporting (“first reported by Reuters”). Those articles relay the story; they are not independent confirmation. Here: Each article presents its own reporting.
Unnamed sources 1 of 5
The main claim is attributed to people who are not identified: “people familiar with the matter”, “officials said”. The count is how many articles do this.
How it developed
When the first report landed and whether it named anyone; when the first named source and the first document appeared. Here: First report Oct 22, 23:15 UTC by TechCrunch, naming its source. First document in the first report, from TechCrunch (press release).
Not counted 0
Opinion, analysis and video pieces, and articles too short to assess. Every count above is out of the counted articles. An article republished under a new headline is one article.
This is about who is cited, not whether the story is true. Each source below says what it names. How we count
Omitted — what each side leaves out

Unpacked

Left-leaning coverage never says Warhound will start by cloning elite dogs already in service. Business Insider and Mother Jones present a genetically engineered war-dog project aimed at speed and bomb sniffing, and omit that blood has already been taken from military and police animals for cloning. Right-leaning coverage puts that cloning step first, then health-focused gene edits, before any talk of enhanced smell or armor. Mother Jones opens on designer pets and frames the launch as part of "the right-wing obsession with genetic optimization." The New York Post leads with Silicon Valley funding and a superhero analogy instead, and does not mention those political ties. None of the coverage says whether the Pentagon or any police force has agreed to buy even one of these dogs.
Bottom line

Left-leaning coverage never uses the word clone, so a Business Insider reader would not know Warhound has already collected blood from elite working dogs to copy them, the opening move only the New York Post reports.

The receipts — 3 facts one side's coverage lacks
  • The U.S. military currently employs about 1,600 dogs numberin Mother Jones · absent from right-leaning coverage
  • 80 percent of U.S. military working dogs are currently sourced from Europe numberin Mother Jones · absent from right-leaning coverage
  • Less than half of dogs who begin the military's training program finish it numberin Mother Jones · absent from right-leaning coverage
The Left View
Mother Jones casts the launch as weapons-tech entrepreneurs joining the “designer-dog market” and as “another manifestation of the right-wing obsession with genetic optimization—you could call it the science of good genes,” analogizing it to Silicon Valley efforts to “engineer designer genius babies.” It emphasizes that backers include “far-right billionaire Joe Lonsdale’s 8VC” and In-Q-Tel, “founded by the CIA and linked with far-right billionaire Peter Thiel,” and says a company release “describes dogs as if they were critical minerals.” The magazine treats Colossal’s earlier “dire wolves” as “merely genetically-modified versions of extant wolves, not a whole-cloth recreation of an extinct species,” implying similar overclaim in the plan to create “a new type of dog.” Business Insider, by contrast, foregrounds the welfare pitch—that healthier animals will “limit the number who enter unnecessary intensive training and enable safer missions”—and Luckey’s line that “Man’s best friend deserves man’s best tech.”
The Right View
The New York Post frames the project as a patriotic sci-fi upgrade—“the dogs of war could soon be getting a DNA upgrade”—that could add “wolf-like sniffing powers” and “high-tech combat armor,” and it highlights Lamm’s “Captain America meets Iron Man” description. Coverage stresses a domestic alternative to European breeders, cloning of already-elite working dogs, and gene edits aimed at known ailments, while noting Lamm’s insistence that Anduril’s contribution is worn gear such as “advanced body armor,” not “surgically implanted electronics.” It quotes the American Humane Society applauding Warhound and Colossal for giving the organization “a seat at the table” to help “ensure the animals in their care are treated humanely,” even as it records that producing animals with “reliably superior abilities—without introducing new health problems—remains unproven” and that cloning brings reproductive challenges and likely animal-rights opposition.
Our Take (balanced)
The left’s strongest argument is that this is genetic-optimization ideology applied to living combat tools, with Colossal’s scientifically disputed dire-wolf claims as the best evidence that marketing may outrun what gene editing can actually produce. The right’s strongest argument is that a high-washout, Europe-dependent working-dog pipeline is a real capability gap, and that cloning proven animals, editing known disease, and adding external armor—under Humane Society oversight—is a concrete supply and welfare response rather than a comic-book experiment. The central unresolved tension is whether redesigning dogs for war is a legitimate way to make a necessary military asset healthier and homegrown, or an ethically fraught bet whose promised enhancements have not been shown in animals.

5 sources

More stories

The week's bottom lines, in your inbox

One email a week: the five stories that mattered and what they actually mean. Free.